They are currently widely used in the study of glaucoma (Sayyad et al., 2017), macular degeneration (Huang et al., 2022), intraretinal neurodegeneration (Kunimi et al., 2021), and blue light induced retinal lesions
Some people want an easy daily option
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting clinical evaluations of miniature, subdermal GLP-1 implants for obesity reduction Development partner, Okava Pharmaceuticals, is studying OKV-119 for the treatment of pre-diabetes, diabetes, and obesity in companion felines ALAMEDA, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc
Javaslatok: tallja meg a kiegszt rutinjt Mindenkinek ms az tja a GLP-1 gygyszerekkel